Royalty Pharma reports first quarter 2026 results
Go back to Royalty Pharma reports first quarter 2026 results| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 54.28 -1.07 (1.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.35 | 52 Week High | $3.48 | |||
| Open | $55.16 | 52 Week Low | $0.80 | |||
| Day High | $55.57 | P/E | N/A | |||
| Day Low | $54.20 | EPS | $-1.54 | |||
| Volume | 4,314,610 | |||||
